institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published United StatesUpdated

Anti-amyloid therapy may keep Alzheimer’s symptoms at bay in certain patients, study suggests

  • Scientists have found that a biologic drug can delay Alzheimer's symptoms in specific patients, marking a significant step in treatment options.
  • The study revealed a 50% reduction in risk of symptoms for 22 patients who took gantenerumab for an average of eight years.
  • Dr. Eric McDade stated that these results suggest a possibility of delaying Alzheimer's progression.
  • Dr. Tara Spires-Jones noted that while results are promising, they do not conclusively prove delayed onset, and some might avoid treatment due to modest benefits.
Does this summary seem wrong?

249 Articles

All
Left
30
Center
113
Right
16
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 71% of the sources are Center
71% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Futura broke the news in on Wednesday, March 19, 2025.
Sources are mostly out of United States (76)

You have read 1 out of your 5 free daily articles.

Our use of cookies
Unlike other news sites, we do not share or sell your data to third-parties for targeted ads.
By continuing to use our application or website, you agree to our Terms of Service and Privacy Policy.